News

EraPerMed Joint Transnational Call 2022: Prevention in personalised medicine

Published on: 03/05/2022

EraPerMed Joint Transnational Call 2022: Prevention in personalised medicine
Funding
Member News, Funding news

Through its fifth transnational call, ERA PerMed aims to foster research on prevention in personalised medicine. The overarching goal of the call is the development of tailor-made strategies for prevention of disease and disease progression, at three different levels: i. preventive measures decreasing the rate of incidence (primary prevention), ii. early detection to increase the efficacy of a preventive therapy, even before symptoms are developed (secondary prevention), and iii. interventions preventing disease recurrence or improving patients’ care and quality of life (tertiary prevention). Research on prevention from over-treatment or overmedicalisation in primary, secondary and tertiary personalised preventive approaches is optional and could be part of research proposals, if applicable.

Deadline for full proposals is 14 June 2022. For more information, check ERA PerMed website. 

NEWS​

Related News

VUGENE secures 1 million Euros to revolutionize biological research

7 May 2025
VUGENE, a Lithuania-based multi-omics data analysis company, has announced the closing an investment round of €1 million, led by Superhero Capital tog...

AMR EDUCare: Empowering europe’s healthcare professionals to tackle antimicrobial resistance

6 May 2025

Connect, Innovate, and Transform Healthcare at the AHB Symposium 2025

6 May 2025

Shaping the Future of Digital Health: Insights from the Foresight 2030 Study

6 May 2025

MedFIT 2025

6 May 2025

Have your say: Open Public Consultation for the BeWell Skills Strategy (DUPLICATE)

6 May 2025

Become a member

Join ECHAlliance to amplify your organisation’s message, grow your networks, connect with innovators and collaborate globally.
 
First name *
Last Name *
Email Address *
Country *
Position *
First name *
Last Name *
Email Address *
Country *
Position *